1.23. Analysis.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 23 Number who suffered at least one adverse event of confusion before end of treatment at 6 months or later.
Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 23 Number who suffered at least one adverse event of confusion before end of treatment at 6 months or later.